PALI
Price
$1.71
Change
-$0.04 (-2.29%)
Updated
Dec 24 closing price
WINT
Price
$0.30
Change
-$0.02 (-6.25%)
Updated
Dec 24 closing price
Ad is loading...

PALI vs WINT

Header iconPALI vs WINT Comparison
Open Charts PALI vs WINTBanner chart's image
Palisade Bio
Price$1.71
Change-$0.04 (-2.29%)
Volume$106.96K
CapitalizationN/A
Windtree Therapeutics
Price$0.30
Change-$0.02 (-6.25%)
Volume$673.54K
CapitalizationN/A
PALI vs WINT Comparison Chart
Loading...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PALI vs. WINT commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PALI is a Hold and WINT is a Hold.

COMPARISON
Comparison
Dec 25, 2024
Stock price -- (PALI: $1.71 vs. WINT: $0.30)
Brand notoriety: PALI and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PALI: 6% vs. WINT: 47%
Market capitalization -- PALI: $5.07M vs. WINT: $2.73M
PALI [@Biotechnology] is valued at $5.07M. WINT’s [@Biotechnology] market capitalization is $2.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PALI’s FA Score shows that 1 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • PALI’s FA Score: 1 green, 4 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than PALI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PALI’s TA Score shows that 5 TA indicator(s) are bullish while WINT’s TA Score has 3 bullish TA indicator(s).

  • PALI’s TA Score: 5 bullish, 3 bearish.
  • WINT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PALI is a better buy in the short-term than WINT.

Price Growth

PALI (@Biotechnology) experienced а -10.00% price change this week, while WINT (@Biotechnology) price change was -20.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.88%. For the same industry, the average monthly price growth was -1.84%, and the average quarterly price growth was +2.99%.

Reported Earning Dates

PALI is expected to report earnings on May 11, 2023.

WINT is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Biotechnology (-0.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PALI($5.07M) has a higher market cap than WINT($2.73M). WINT has higher P/E ratio than PALI: WINT (0.83) vs PALI (0.02). PALI YTD gains are higher at: -80.678 vs. WINT (-97.489). WINT has higher annual earnings (EBITDA): -9.36M vs. PALI (-14.05M). PALI has more cash in the bank: 8.04M vs. WINT (2.3M). PALI has less debt than WINT: PALI (357K) vs WINT (2.01M). PALI (0) and WINT (0) have equivalent revenues.
PALIWINTPALI / WINT
Capitalization5.07M2.73M186%
EBITDA-14.05M-9.36M150%
Gain YTD-80.678-97.48983%
P/E Ratio0.020.832%
Revenue00-
Total Cash8.04M2.3M350%
Total Debt357K2.01M18%
FUNDAMENTALS RATINGS
PALI vs WINT: Fundamental Ratings
PALI
WINT
OUTLOOK RATING
1..100
3250
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9698
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PALI's Valuation (20) in the null industry is somewhat better than the same rating for WINT (61) in the Biotechnology industry. This means that PALI’s stock grew somewhat faster than WINT’s over the last 12 months.

PALI's Profit vs Risk Rating (100) in the null industry is in the same range as WINT (100) in the Biotechnology industry. This means that PALI’s stock grew similarly to WINT’s over the last 12 months.

PALI's SMR Rating (99) in the null industry is in the same range as WINT (99) in the Biotechnology industry. This means that PALI’s stock grew similarly to WINT’s over the last 12 months.

PALI's Price Growth Rating (96) in the null industry is in the same range as WINT (98) in the Biotechnology industry. This means that PALI’s stock grew similarly to WINT’s over the last 12 months.

WINT's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for PALI (100) in the null industry. This means that WINT’s stock grew significantly faster than PALI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PALIWINT
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
PALI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME30.901.08
+3.62%
GameStop Corp
TSLA430.609.54
+2.27%
Tesla
SPY594.693.54
+0.60%
SPDR® S&P 500® ETF Trust
AAPL255.270.78
+0.31%
Apple
BTC.X94686.240000-418.695300
-0.44%
Bitcoin cryptocurrency

PALI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
-2.29%
CDTX - PALI
82%
Closely correlated
+0.13%
WINT - PALI
81%
Closely correlated
-6.52%
SNPX - PALI
81%
Closely correlated
+3.23%
NCNA - PALI
81%
Closely correlated
-0.41%
NBY - PALI
80%
Closely correlated
+4.49%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been closely correlated with CDTX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if WINT jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
+1.50%
CDTX - WINT
94%
Closely correlated
+0.78%
NCNA - WINT
92%
Closely correlated
N/A
SNPX - WINT
92%
Closely correlated
-4.23%
NBY - WINT
92%
Closely correlated
-2.49%
AGEN - WINT
91%
Closely correlated
-3.89%
More